Direxion Daily S&P Biotech Bear 3X ETF
LABD
LABD
16 hedge funds and large institutions have $29.9M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 7 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less ownership
Funds ownership: →
6% less funds holding
Funds holding: 17 → 16 (-1)
29% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 7
Holders
16
Holding in Top 10
–
Calls
$25.3M
Puts
$7.61M
Top Buyers
| 1 | +$5.5M | |
| 2 | +$2.83M | |
| 3 | +$2.12M | |
| 4 |
JF
Jump Financial
Chicago,
Illinois
|
+$2M |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.74M |
Top Sellers
| 1 | -$4.22M | |
| 2 | -$2.61M | |
| 3 | -$1.16M | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$966K |
| 5 |
Goldman Sachs
New York
|
-$662K |